Form 483

Sam Van Boxstael, M.D. Form 483, 2018-01-19

FDA issued a Form 483 to Sam Van Boxstael, M.D. on 2018-01-19 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Sam Van Boxstael, M.D. · Genk, Belgium · Issued January 19, 2018

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 Jan 2018
21 CFR 312.60

FD-1572, protocol compliance

Cited by Sherri N Rohlf, Jenn W Sellers

19 Jan 2018
21 CFR 312.62(b)

Case history records- inadequate or inadequate

Cited by Sherri N Rohlf, Jenn W Sellers

Inspected site

SVSam Van Boxstael, M.D.Genk, Belgium

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.60Cited across public-safe Form 483 observations1x
21 CFR 312.62(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 2 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere